Abstract:Nanomedicines have achieved several successful clinical applications for cancer therapy over the past decades. To date, numerous nanomedicine formats and design rationales have been proposed to improve pharmaceutical delivery and treatment efficacy. Despite these advances, the achievement of high drug loading and loading efficiencies of drug payloads in nanocarriers remains a technical challenge. In addition, study of the correlation between therapeutic potential and drug loading has been ignored. Here, using a self-assembling dimeric cabazitaxel prodrug, we show that the prodrug can be quantitatively entrapped within clinically approved polymer matrices for intravenous injection and that the drug loading in the nanoparticles (NPs) is tunable. The engineered NPs (NPs1-4) with different drug loading values exhibit dissimilar morphologies, release kinetics, in vitro cytotoxic activity, pharmacokinetic properties, tissue distribution, and in vivo anticancer efficacy and safety profiles. Furthermore, the effect of drug loading on the treatment outcomes was explored through detailed in vitro and in vivo studies. Intriguingly, among the constructed NPs, those comprising poly(ethylene glycol)-block-poly(D,L-lactic acid) (PEG-PLA) copolymers showed substantially prolonged pharmacokinetic properties in the blood circulation, which further promoted their intratumoral delivery and accumulation. Furthermore, the PEG-PLA-composed NPs with high drug loading (~50%) demonstrated favorable efficacy and safety profile in animal models. These data provide convincing evidence that the in vivo performance of a given self-assembling drug is not compromised by high drug loading in nanoplatforms, which may potentially reduce concerns over excipient-associated side effects and immunotoxicities. Overall, our study provides new insight into the rationale for designing more effective and less toxic delivery systems.

Poly(lactic Acid) (PLA) Based Nanocomposites--a Novel Way of Drug-Releasing.

Novel Strategy to Fabricate PLA/Au Nanocomposites As an Efficient Drug Carrier for Human Leukemia Cells in Vitro

The Application of New Nanocomposites: Enhancement Effect of Polylactide Nanofibers/nano-Tio2 Blends on Biorecognition of Anticancer Drug Daunorubicin

Electrochemical Study on Synergistic Effect of the Blending of Nano TiO2 and PLA Polymer on the Interaction of Antitumor Drug with DNA

Novel Nanocomposite Of Nano Fe3o4 And Polylactide Nanofibers For Application In Drug Uptake And Induction Of Cell Death Of Leukemia Cancer Cells

Blends of TiO2 nanoparticles and poly (N-isopropylacrylamide)-co-polystyrene nanofibers as a means to promote the biorecognition of an anticancer drug.

Self-assembled Amphiphilic Copolymers–doxorubicin Conjugated Nanoparticles for Gastric Cancer Therapy with Low in Vivo Toxicity and High Efficacy

PLLAGrafted Gelatin Amphiphilic Copolymer and Its SelfAssembled Nano Carrier for Anticancer Drug Delivery

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

The application of poly(N-isopropylacrylamide)-co-polystyrene nanofibers as an additive agent to facilitate the cellular uptake of an anticancer drug.

Controlled Release of Multiple Hydrophilic and Hydrophobic Drugs and in vitro Cytotoxicity of Electrospun Poly(lactic-co-glycolic acid)/ZnO Nanofibers Encapsulated with Dual Drugs

Multicomponent Polymeric Nanoparticles Enhancing Intracellular Drug Release in Cancer Cells

Encapsulating Doxorubicin-Intercalated Lamellar Nanohydroxyapatite into PLGA Nanofibers for Sustained Drug Release

Preparation and Characterization of Electrospun PLGA-SF Nanofibers As a Potential Drug Delivery System

Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.

Nano Micelles of Cellulose-Graft-poly (L-Lactic Acid) Anchored with Epithelial Cell Adhesion Antibody for Enhanced Drug Loading and Anti-Tumor Effect

Nanostructured Poly(l-Lactide) Matrix As Novel Platform for Drug Delivery

Controlled Dual Drug Release and in Vitro Cytotoxicity of Electrospun Poly(Lactic-Co-Glycolic Acid) Nanofibers Encapsulated with Micelles

[Preparation and Release Efficiency of Polylactic Acid Nanoparticle].

The Preparation of PLGA-PLL-Peg Nanoparticles Simultaneously Loaded with Daunorubicin and Tetrandrine by Modified Double-Emulsion Method

Preparation and Characterization of Zwitterionic Phospholipid Polymer-Coated Poly(lactic Acid) Nanoparticles